JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 2007; 50:1362-1369, doi:10.1016/j.jacc.2007.06.035 (Published online 14 September 2007).
© 2007 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
j.jacc.2007.06.035v1
50/14/1362    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sebastiani, M.
Right arrow Articles by d’Amati, G.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Sebastiani, M.
Right arrow Articles by d’Amati, G.

CLINICAL RESEARCH: CARDIOMYOPATHY

Induction of Mitochondrial Biogenesis Is a Maladaptive Mechanism in Mitochondrial Cardiomyopathies

Mariangela Sebastiani, BSc*, Carla Giordano, MD, PhD*, Chiara Nediani, BSc{ddagger}, Claudia Travaglini, BSc*, Elisabetta Borchi, BSc{ddagger}, Massimo Zani, BSc*, Mariano Feccia, MD§, Massimiliano Mancini, MD*, Vincenzo Petrozza, MD{dagger}, Andrea Cossarizza, MD||, Pietro Gallo, MD*, Robert W. Taylor, PhD# and Giulia d’Amati, MD, PhD*,*

* Dipartimento di Medicina Sperimentale, Polo Pontino, Sapienza, Università di Roma, Rome, Italy
{dagger} Dipartimento di Medicina Sperimentale, Polo Pontino, Sapienza, Università di Roma, Rome, Italy
{ddagger} Dipartimento di Scienze Biochimiche, Università di Firenze, Florence, Italy
§ Dipartimento di Cardiochirurgia, Azienda Ospedaliera S. Camillo, Rome, Italy
|| Dipartimento di Scienze Biomediche, Sezione di Patologia Generale, Università di Modena e Reggio Emilia, Modena, Italy
# Mitochondrial Research Group and Institute of Human Genetics, Newcastle University, Newcastle upon Tyne, United Kingdom.

Manuscript received February 28, 2007; revised manuscript received May 11, 2007, accepted June 3, 2007.

* Reprint requests and correspondence: Dr. Giulia d’Amati, Dipartimento di Medicina Sperimentale, La Sapienza, Università di Roma, Viale Regina Elena 324, 00161 Rome, Italy. (Email: giulia.damati{at}uniroma1.it).

Objectives: The purpose of this study was to clarify the molecular mechanisms linking human mitochondrial deoxyribonucleic acid (mtDNA) dysfunction to cardiac remodeling.

Background: Defects of the mitochondrial genome cause a heterogeneous group of clinical disorders, including mitochondrial cardiomyopathies (MIC). The molecular events linking mtDNA defects to cardiac remodeling are unknown. Energy derangements and increase of mitochondrial-derived reactive oxygen species (ROS) could both play a role in the development of cardiac dysfunction in MIC. In addition, mitochondrial proliferation could interfere with sarcomere alignment and contraction.

Methods: We performed a detailed morphologic and molecular analysis on failing hearts from 3 patients with MIC, failing human hearts due to ischemic heart disease (IHD) or dilated cardiomyopathies (DCM), and nonfailing hearts.

Results: The MIC hearts showed marked mitochondrial proliferation with myofibril displacement. Consistent with morphologic features, increase in mtDNA content per cell and induction of genes involved in mitochondrial biogenesis, fatty acid metabolism, and glucose transport were observed. Down-regulation of these genes characterized DCM and IHD hearts. A pronounced increase in mitochondrial-derived ROS was observed in MIC hearts compared with failing hearts due to other causes. This was paralleled by up-regulation of genes encoding for uncoupling proteins and antioxidant enzymes. However, there was not a significant increase in antioxidant enzyme activity.

Conclusions: Our results suggest that besides energy deficiency, mitochondrial biogenesis per se is a maladaptive response in MIC and, possibly, in other metabolic cardiomyopathies.

Abbreviations and Acronyms
  ANF = atrial natriuretic factor
  DCM = dilated cardiomyopathy
  GLUT = glucose transporter
  GPX = glutathione peroxidase
  IHD = ischemic heart disease
  mCPT-I = carnitine palmitoyl transferase muscle isoform
  MIC = maternally inherited cardiomyopathy
  MnSOD = manganese superoxide dismutase
  mtDNA = mitochondrial deoxyribonucleic acid
  mt-tRNAIle = mitochondrial transfer ribonucleic acid isoleucine
  NADPH = nicotinamide adenine dinucleotide 3-phosphate
  PCR = polymerase chain reaction
  PGC = peroxisome proliferator activated receptor {gamma} coactivator
  PPAR = peroxisome proliferator activated receptor
  Tfam = transcription and mitochondrial DNA maintenance factor




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
R. Ventura-Clapier, A. Garnier, and V. Veksler
Transcriptional control of mitochondrial biogenesis: the central role of PGC-1{alpha}
Cardiovasc Res, July 15, 2008; 79(2): 208 - 217.
[Abstract] [Full Text] [PDF]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2007 by the American College of Cardiology Foundation.